Adenovirus-mediated delivery of antiangiogenic genes as an antitumor approach

Cancer Gene Therapy

Volumn 8, Issue 1, 2001, Pages 45-54

  Regulier E ^a   Paul, S ^a   Marigliano, M ^a   Kintz, J ^a   Poitevin, Y ^a   Ledoux, C ^a   Roecklin, D ^a   Cauet, G ^a   Calenda, V ^a   Homann, H E ^a  

^a TRANSGENE S A   (France)

Author keywords

Angiogenesis; Recombinant adenovirus; Therapy; Tumor

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; ENDOSTATIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; PROLIFERIN RELATED PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER MODEL; CANCER SURVIVAL; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE TARGETING; HUMAN; HUMAN CELL; IMMUNOCOMPETENCE; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR REJECTION; VIRUS EXPRESSION; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALIA; MURINAE;

EID: 0035128136     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700278     Document Type: Article

References (54)

1. The effects of surgical interference with the blood supply on the growth of transplanted carcinomata and sarcomata
2. The transparent chamber technique as a tool in experimental tumor therapy
3. Anti-angiogenesis: New concept for therapy of solid tumors
4. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
5. Clinical applications of angiogenic growth factors and their inhibitors
6. Function of fibroblast growth factors and vascular endothelial growth factors and their receptors in angiogenesis
7. Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis
8. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance
9. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma
10. Cells and cytokines in immunotherapy and gene therapy of cancer
11. Functions of IL-4 and control of its expression
12. Interferons and the tumor cell
13. Direct in vitro evidence and in vivo analysis of the antiangiogenesis effects of interleukin 12
14. Role of C-X-C chemokines as regulators of angiogenesis in lung cancer
15. A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer
16. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
17. Endostatin: Yeast production, mutants, and antitumor effect in renal cell carcinoma
18. Disruption of the KEX1 gene in Pichia pastoris allows expression of full-length murine and human endostatin
19. Angiostatin gene transfer: Inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest
20. Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases
21. Antiangiogenic gene therapy of cancer utilizing a recombinant adenovirus to elevate systemic endostatin levels in mice
22. Combined effects of radiotherapy and angiostatin gene therapy in glioma tumor model
23. Viral vector-mediated transduction of a modified platelet factor 4 cDNA inhibits angiogenesis and tumor growth
24. Effect of in situ retroviral interleukin-4 transfer on established intracranial tumors
25. Systemic delivery of antiangiogenic adenovirus AdmATF induces liver resistance to metastasis and prolongs survival of mice
26. The CXC chemokine, monokine induced by interferon-gamma, inhibits nonsmall cell lung carcinoma tumor growth and metastasis
27. Inhibition of angiogenesis by type I interferons in models of Kaposi's sarcoma
28. Characterization of proliferin-related protein
29. A new member of the prolactin-growth hormone gene family expressed in mouse placenta
30. Stimulation and inhibition of angiogenesis by placental proliferin and proliferin-related protein
31. Biochemical characterization of a gamma interferon-inducible cytokine (IP-10)
32. Human recombinant interferon-inducible protein-10 inhibits the proliferation of normal and acute myelogenous leukemia progenitors
33. IP - 10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo
34. Intratumoral coinjection of two adenoviruses, one encoding the chemokine IFN-gamma-inducible protein-10 and another encoding IL-12, results in marked antitumoral synergy
35. Interferongamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human nonsmall cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases
36. Human interferoninducible protein 10 is a potent inhibitor of angiogenesis in vivo
37. In vivo cancer gene therapy by adenovirus-mediated transfer of a bifunctional yeast cytosine deaminase/uracil phosphoribosyltransferase fusion gene
38. Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding
39. Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins
40. Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli
41. In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2A, or E1/E4 deleted
42. Modified immobilized pH gradient gel strip equilibration procedure in SWISS-2DPAGE protocols
43. Improved staining of proteins in polyacrylamide gels including isoelectric focusing gels with clear background at nanogram sensitivity using Coomassie Brilliant Blue G-250 and R-250
44. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: Insight into mechanisms and implications for cancer growth and ulcer healing
45. Quantitative image analysis of angiogenesis in rats implanted with a fibrin gel chamber
46. Inhibitory effect of full-length human endostatin on in vitro angiogenesis
47. Adenovirus-mediated gene transfer: Influence of transgene, mouse strain and type of immune response on persistence of transgene expression
48. Synergy between angiostatin and endostatin: Inhibition of ovarian cancer growth
49. Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene
50. Liposomes complexed to plasmids encoding angiostatin and endostatin inhibit breast cancer in nude mice
51. Adenovirus-mediated delivery of a uPA/uPAR antagonist suppresses angiogenesis-dependent tumor growth and dissemination in mice
52. Combined effects of angiostatin and ionizing radiation in antitumor therapy
53. Tumor necrosis factor alpha (TNF-alpha) gene therapy targeted by ionizing radiation selectively damages tumor vasculature
54. Spatial and temporal control of gene therapy using ionizing radiation